Clinical Trial Update: Ascorbic Acid Treatment in Congenital Glucocorticoids and Mineralocorticoids Deficiency Due to NNT Mutation [NA]

View source ↗

Summary

A clinical trial is evaluating ascorbic acid as treatment for congenital glucocorticoid and mineralocorticoid deficiency due to NNT mutation. The current study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Insufficiency

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Glucocorticoids Deficiency | NA | Status: UNKNOWN